CompoAtlas

Encens indien BS-85 AKBA

Food supplement declared in France, declaration No 2023-5-517, decision dated 11 May 2023

Encens indien BS-85 AKBA (Biotikon) is a food supplement declared in France. Status: declared in France, may be marketed. Main ingredients: Boswellia serrata 400 mg per day. None of the rules we check flags an issue with its declared composition.

Brand
Biotikon
Food business operator placing the product on the market
Biotikon
Status
Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
Form
Capsule
Daily dose
1
Not recommended (according to the manufacturer)
Adolescents (under 18), Children (under 12), Young children (aged 1 to 3), Pregnant women, Infants (under 1 year), Children (under 6), Children (under 10)
Flavourings
neutre

Declaration 194181, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.

Declared composition

Plants

PlantPartPreparationPer day
Boswellia serrata Roxb. ex Colebr.RésineAutre extrait sec400 mg

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

Photograph the packaging

Regulatory points

None of the rules we check applies to the declared ingredients.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Brand : Biotikon

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “Encens indien BS-85 AKBA (Biotikon): composition and regulation”, https://compoatlas.com/en/supplements/products/194181-encens-indien-bs-85-akba, updated 15 November 2026.

List recorded in 2023. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line